Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships

AIDS

Volumn 26, Issue 4, 2012, Pages 513-518

  Ngure, Kenneth ^a,b   Heffron, Renee ^c   Mugo, Nelly R ^a,c,d   Celum, Connie ^c   Cohen, Craig R ^e   Odoyo, Josephine ^f   Rees, Helen ^g   Kiarie, James N ^a,d   Were, Edwin ^h   Baeten, Jared M ^c  

^a KENYATTA NATIONAL HOSPITAL   (Kenya)

^b KENYATTA UNIVERSITY   (Kenya)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h MOI UNIVERSITY   (Kenya)

Author keywords

Africa; contraception; HIV 1; serodiscordant couples; women

Indexed keywords

INJECTABLE CONTRACEPTIVE AGENT;

ADULT; AFRICA; ARTICLE; CONDOM; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; SEROLOGY; SEXUAL BEHAVIOR; VERTICAL TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AFRICA SOUTH OF THE SAHARA; CONTRACEPTIVES, ORAL; DOUBLE-BLIND METHOD; FAMILY PLANNING SERVICES; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTRAUTERINE DEVICES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84857057219     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834f981c     Document Type: Article

References (23)

1. Sneeringer SE. Fertility transition in sub-Saharan Africa: a comparative analysis of cohort trends in 30 countries. DHS Comparative Reports No. 23. 2009. Calverton, Maryland: ICF Macro.
2. Hubacher D, Mavranezouli I, McGinn E. Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception 2008; 78:73-78.
3. Wilcher R, Petruney T, Reynolds HW, Cates W. From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect 2008; 84 (Suppl 2):ii54-ii60.
4. Mugo NR, Heffron R, Donnell D, Wald A, Were E, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 2011; 25:1887-1895.
5. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-2118.
6. Institute of Medicine (IOM). Methodological challenges in biomedical HIV prevention trials. Washington, District of Columbia: The National Academies Press; 2008.
7. Family Health International. FHI statement on the FEM-PrEP HIV Prevention Study. FHI to initiate orderly closure of FEM-PrEP. 2011. http://www.fhi.org/ en/AboutFHI/Media/Releases/FEMPrEP-statement041811.htm. [Accessed 28 April 2011]
8. Halpern V, Lie C, Feldblum P, Damme L. Predictors of pregnancy in microbicides trials. Contraception 2011; 83:436-440.
9. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, et al. Pregnancy, contraceptive use and HIV acquisition in HPTN039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 2010; 53:606-613.
10. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362: 427-439.
11. Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret A, Baeten J, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the Partners Study. PLoS ONE 2009; 4 Baeten J, Bukusi: e5272.
12. Ngure K, Heffron R, Mugo N, Irungu E, Celum C, Baeten JM, et al. Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. AIDS 2009; 23 (Suppl 1):S89-S95.
13. Efron B. Efficiency of Cox's likelihood function for censored data. J Am Statist Assoc 1977; 72:557-565.
14. WHO. Department of Reproductive Health and Research. Selected practice recommendations for contraceptive use. 2nd ed. 2004. pp. 5-7. http://www.who.int/reproductivehealth/publi cations/family-planning/ 9241562846index/en/index.html.
15. Guthrie B, Gatuguta A, Bosire R, Kiarie JN, Mackelprang RD, Gatuguta A, et al. Predicting pregnancy among HIV-1 discordant couples. AIDS Behav 2010; 14:1066-1071.
16. Clifton D, Kaneda T, Ashford L. Family planning worldwide: 2008 data sheet. Washington, District of Columbia: Population Reference Bureau; 2008.
17. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007; 197:e1-e8.
18. Gutin SA, Mlobeli R, Moss M, Buga G, Morroni C. Survey of knowledge, attitudes and practices surrounding the intrauterine device in South Africa. Contraception 2011; 83:145-215.
19. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
20. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001; 17:901-910. (Pubitemid 32881333)
21. Ngure K, Mugo N, Celum C, Baeten JM, Morris M, Olungah O, et al. A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. AIDS Care 2011 [Epub ahead of print].
22. Heffron R, Donnell D, Rees H, Celum C, Were E, Mugo N, et al. Hormonal contraceptive use and risk of HIV-1 transmission: a prospective cohort analysis. Lancet Infect Dis 2011. doi: 10.1016/S1473-3099(11)70247-X. [Epub ahead of print].
23. Holmes KK, Levine R, Weaver M. Effectiveness of condomsin preventing sexually transmitted infections. Bull World Health Organ 2004; 82:454-461. (Pubitemid 38828432)